Skip to Content
Merck
CN

P1722

Potassium citrate tribasic monohydrate

crystals, meets USP testing specifications

Synonym(s):

Citric acid tripotassium salt, Tripotassium citrate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
HOC(COOK)(CH2COOK)2 · H2O
CAS Number:
6100-05-6
Molecular Weight:
324.41
NACRES:
NA.21
PubChem Substance ID:
57654504
UNSPSC Code:
12352100
EC Number:
231-905-0
MDL number:
MFCD00150442
Beilstein/REAXYS Number:
3924344
Assay:
100.10%
Form:
crystals

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Potassium citrate tribasic monohydrate, meets USP testing specifications

InChI key

PJAHUDTUZRZBKM-UHFFFAOYSA-K

InChI

1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3

SMILES string

O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

agency

USP/NF
meets USP testing specifications

Quality Level

200

assay

100.10%

form

crystals

mp

275 °C (dec.) (lit.)

application(s)

pharmaceutical (small molecule)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Potassium citrate tribasic monohydrate (KCTM) is a potassium salt that has been reported to be efficient in forming aqueous two-phase system (ATPS) with UCON 50-HB-5100, a random copolymer. This product is a high quality pharmacopoeia product that meets the testing specifications of USP (United States Pharmacopoeia). It can be employed in research and pilot studies.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000504151
0000504151
0000483811
0000483811
0000477855

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

(Liquid+ liquid) equilibria of polymer-salt aqueous two-phase systems for laccase partitioning: UCON 50-HB-5100 with potassium citrate and (sodium or potassium) formate at 23?C.
Lladosa E, et al.
The Journal of Chemical Thermodynamics, 55, 166-171 (2012)
Donna J Claes et al.
Pediatric nephrology (Berlin, Germany), 27(11), 2031-2038 (2012-01-28)
Cystinuria is a relatively uncommon cause of pediatric stone disease, but has significant morbidity if not properly controlled because of its significant stone recurrence rate. Cystinuria is caused by the inability of the renal tubules to reabsorb filtered cystine, which
Naim M Maalouf et al.
The Journal of clinical endocrinology and metabolism, 96(12), 3733-3740 (2011-10-07)
Dietary intake of animal proteins is associated with an increase in urinary calcium and nephrolithiasis risk. We tested the hypothesis that the acid load imposed by dietary proteins causes this hypercalciuria. In a short-term crossover metabolic study, an alkali salt
Pierre Cochat et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27(5), 1729-1736 (2012-05-02)
Primary hyperoxaluria Type 1 is a rare autosomal recessive inborn error of glyoxylate metabolism, caused by a deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase. The disorder results in overproduction and excessive urinary excretion of oxalate, causing recurrent urolithiasis and nephrocalcinosis.
Khashayar Sakhaee et al.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 8(1), 67-72 (2011-06-28)
Patients undergoing Roux-en-Y gastric bypass (RYGB) surgery are prone to developing bone loss and kidney stones. The goal of the present study was to test the hypothesis that an effervescent formulation of potassium calcium citrate (PCC) would avert metabolic complications
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service